Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.84K Buy
57
+22
+63% +$2.24K ﹤0.01% 2505
2025
Q4
$3.52K Buy
35
+8
+30% +$789 ﹤0.01% 2581
2025
Q3
$2.33K Buy
27
+6
+29% +$474 ﹤0.01% 2591
2025
Q2
$1.6K Buy
+21
New +$1.54K ﹤0.01% 2492
2025
Q1
Sell
-1
Closed -$78 2719
2024
Q4
$78 Buy
+1
New +$93 ﹤0.01% 2550

Other funds holding NUVL

AssetMark Inc's NUVL Position: Q1 2026 in Review

AssetMark Inc increased its Nuvalent (NUVL) stake by 63% in Q1 2026, buying an estimated $2.24K and bringing the position to 57 shares worth $5.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

AssetMark Inc first reported a position in NUVL in Q4 2024 and has held it in 5 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • AssetMark Inc held 57 shares of Nuvalent worth $5.84K as of Q1 2026.
  • AssetMark Inc bought 22 Nuvalent shares in Q1 2026, an estimated $2.24K.
  • Nuvalent made up ﹤0.01% of AssetMark Inc's portfolio in Q1 2026, its #2505 holding.
  • AssetMark Inc first reported a position in Nuvalent in Q4 2024 and has held it in 5 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.